Bibliography

Found 15 results

Filters: Keyword is Cytokines [Clear All Filters]

Journal Article

Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, et al. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 ;68(3):281-8.

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014 ;28(11):1579-91.

Langford D, Masliah E. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathology (Zurich, Switzerland) [Internet]. 2001 ;11(3):306-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11414473

Tatro ET, Soontornniyomkij B, Letendre SL, Achim CL. Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect Dis. 2014 ;14:386.

Fiala M, Popik W, Qiao JH, Lossinsky AS, Alce T, Tran K, Yang W, Roos KP, Arthos J. HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovascular Toxicology [Internet]. 2004 ;4(2):97-107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15371627

Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, Le K, Loftus AW, Schwartz SA, Quigg RJ, et al. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest. 2017 ;46(8):816-832.

Ríos-Olivares E, Vilá LM, Reyes JC, Rodríguez JW, J Colón HM, Pagán NO, Marrero A, Ríos-Orraca ZM, Boukli NM, Shapshak P, et al. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend. 2006 ;85(3):236-43.

Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J Neuroinflammation. 2015 ;12:72.

Suh H-S, Gelman B, Lee SC. Potential Roles of Microglial Cell Progranulin in HIV-Associated CNS Pathologies and Neurocognitive Impairment. Journal of Neuroimmune Pharmacology: the official journal of the Society on NeuroImmune Pharmacology [Internet]. 2013 ;9(2):117-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23959579

Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore DJ, Heizerling K, et al. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 ;29(12):1483-91.

Yoshioka M, Bradley W, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava A, Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol. 1995 ;5(3):335-58.

Langford D, Masliah E. Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases. Journal of Neurovirology [Internet]. 2002 ;8(6):625-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12476355

Kamat A, Ancuta P, Blumberg RS, Gabuzda D. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PloS One [Internet]. 2010 ;5:e15533. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21125014

Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MCatherine, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, et al. Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. AIDS. 2018 ;32(9):1147-1156.

Gelman BB, Endsley J, Kolson D. When do models of NeuroAIDS faithfully imitate "the real thing"?. J Neurovirol. 2018 ;24(2):146-155.